comparemela.com
  1. Home
  2. Live Updates
  3. Chengdu Regional Head Office Rd Center - Breaking News

Latest Breaking News On - Chengdu regional head office rd center - Page 1 : comparemela.com

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience s Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma

/PRNewswire/ Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company s lead innovative.

Feng wangUnited statesRuihua xuSun yatXianping luChidamide tucidinostatChipscreen biosciencesWeili zhaoChidamide epidazaData monitoring committeeChipscreen biosciences united states co ltdPrnewswire shenzhen chipscreen biosciences co ltdChengdu small molecule early rd centerShanghai jiao tong university school of medicineChengdu regional head office rd centerShenzhen chipscreen biosciences co ltd

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.